![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SIF BANAT-CRISANA INCREASES STAKE IN BIOFARM
SIF BANAT-CRISANA INCREASES STAKE IN BIOFARM
June 6, 2006
SIF Banat-Crisana reached a share of 10 per cent in the capital of the pharmaceutical company Biofarm, following several transactions carried on through the Bucharest Stock Exchange (BVB). SIF Banat-Crisana previously held 35.6 million Biofarm shares, standing for 9.9 per cent, informs the financial investment company's communiqué sent to BVB.
Reporter.gr (http://www.reporter.gr/fulltext_eng.cfm?id=60606142727)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct